Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer

NCT02856100 · clinicaltrials.gov ↗

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: 18F DCFPyL- Radiopharmaceutical

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]